Primary Site >> Colorectal Cancer

Gene >> ENOSF1

Journal: Gut. 2015 Jan;64(1):111-20.
Title: A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMS.
Author: Rosmarin, Dan|Palles, Claire|Pagnamenta, Alistair|Kaur, Kulvinder|Pita, Guillermo|Martin, Miguel|Domingo, Enric|Jones, Angela|Howarth, Kimberley|Freeman-Mills, Luke|Johnstone, Elaine|Wang, Haitao|Love, Sharon|Scudder, Claire|Julier, Patrick|Fernandez-Roza
PMID: 24647007
Journal: Oncotarget. 2015 Mar 20;6(8):6422-30.
Title: Variants in CDA and ABCB1 are predictors of capecitabine-related adverse reactions in colorectal cancer.
Author: Garcia-Gonzalez, Xandra|Cortejoso, Lucia|Garcia, Maria I|Garcia-Alfonso, Pilar|Robles, Luis|Gravalos, Cristina|Gonzalez-Haba, Eva|Marta, Pellicer|Sanjurjo, Maria|Lopez-Fernandez, Luis A
PMID: 25691056
Journal: Pharmacol Res. 2017 Jun;120:133-137.
Title: Identification of new SNPs associated with severe toxicity to capecitabine.
Author: Pellicer, Marta|Garcia-Gonzalez, Xandra|Garcia, Maria I|Robles, Luis|Gravalos, Cristina|Garcia-Alfonso, Pilar|Pachon, Vanessa|Longo, Federico|Martinez, Virginia|Blanco, Carolina|Iglesias, Irene|Sanjurjo, Maria|Lopez-Fernandez, Luis A
PMID: 28347776